2728 related articles for article (PubMed ID: 18005909)
21. A randomized, double-blind, placebo-controlled, clinical dose-response trial of an extract of Baptisia, Echinacea and Thuja for the treatment of patients with common cold.
Naser B; Lund B; Henneicke-von Zepelin HH; Köhler G; Lehmacher W; Scaglione F
Phytomedicine; 2005 Nov; 12(10):715-22. PubMed ID: 16323289
[TBL] [Abstract][Full Text] [Related]
22. Clinical validation of efficacy and safety of herbal cough formula: study of herbal cough syrup.
Nesari T; Bhagwat BK; Johnson J; Bhatt NS; Chitre D
J Herb Pharmacother; 2004; 4(4):1-12. PubMed ID: 15927921
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial.
Matthys H; Eisebitt R; Seith B; Heger M
Phytomedicine; 2003; 10 Suppl 4():7-17. PubMed ID: 12807337
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of roxithromycin in adult patients with rheumatoid arthritis who had not received disease-modifying antirheumatic drugs: a 3-month, randomized, double-blind, placebo-controlled trial.
Ogrendik M
Clin Ther; 2009 Aug; 31(8):1754-64. PubMed ID: 19808134
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
[TBL] [Abstract][Full Text] [Related]
26. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
[TBL] [Abstract][Full Text] [Related]
27. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis.
Hubbert M; Sievers H; Lehnfeld R; Kehrl W
Eur J Med Res; 2006 Jan; 11(1):20-6. PubMed ID: 16504956
[TBL] [Abstract][Full Text] [Related]
29. A randomized double blind placebo controlled clinical evaluation of extract of Andrographis paniculata (KalmCold) in patients with uncomplicated upper respiratory tract infection.
Saxena RC; Singh R; Kumar P; Yadav SC; Negi MP; Saxena VS; Joshua AJ; Vijayabalaji V; Goudar KS; Venkateshwarlu K; Amit A
Phytomedicine; 2010 Mar; 17(3-4):178-85. PubMed ID: 20092985
[TBL] [Abstract][Full Text] [Related]
30. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
[TBL] [Abstract][Full Text] [Related]
31. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
Cady R; Schreiber C
Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and tolerability of tapentadol immediate release and oxycodone HCl immediate release in patients awaiting primary joint replacement surgery for end-stage joint disease: a 10-day, phase III, randomized, double-blind, active- and placebo-controlled study.
Hartrick C; Van Hove I; Stegmann JU; Oh C; Upmalis D
Clin Ther; 2009 Feb; 31(2):260-71. PubMed ID: 19302899
[TBL] [Abstract][Full Text] [Related]
33. Onset of action of fexofenadine hydrochloride 60 mg/pseudoephedrine hydrochloride 120 mg in subjects aged 12 years with moderate to severe seasonal allergic rhinitis: a pooled analysis of two single-dose, randomized, double-blind, placebo-controlled allergen exposure unit studies.
Berkowitz RB; McCafferty F; Lutz C; Bazelmans D; Godfrey P; Meeves S; Liao Y; Georges G
Clin Ther; 2006 Oct; 28(10):1658-69. PubMed ID: 17157121
[TBL] [Abstract][Full Text] [Related]
34. Treatment for seasonal allergic rhinitis by Chinese herbal medicine: a randomized placebo controlled trial.
Xue CC; Thien FC; Zhang JJ; Da Costa C; Li CG
Altern Ther Health Med; 2003; 9(5):80-7. PubMed ID: 14526714
[TBL] [Abstract][Full Text] [Related]
35. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
[TBL] [Abstract][Full Text] [Related]
36. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Marple BF; Roberts CS; de Caprariis PJ; Reisman A
Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
[TBL] [Abstract][Full Text] [Related]
37. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study.
Cheung R; Krishnaswami S; Kowalski K
Clin Ther; 2007; 29 Suppl():2498-510. PubMed ID: 18164917
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of a fixed combination of thyme and primrose root in patients with acute bronchitis. A double-blind, randomized, placebo-controlled clinical trial.
Gruenwald J; Graubaum HJ; Busch R
Arzneimittelforschung; 2005; 55(11):669-76. PubMed ID: 16366041
[TBL] [Abstract][Full Text] [Related]
39. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
40. The nasal decongestant effect of xylometazoline in the common cold.
Eccles R; Eriksson M; Garreffa S; Chen SC
Am J Rhinol; 2008; 22(5):491-6. PubMed ID: 18655753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
